Children hospitalized with Alagille syndrome commonly had narrowing in the branches of the pulmonary artery, which carries blood from the heart to the lungs,…
News
People in the European Union with acute hepatitis C virus (HCV) infections now have a new treatment option: Abbvie’s Maviret (glecaprevir/pibrentasvir). EU regulators have…
Various factors, including male sex and younger age, were associated with an increased risk of primary sclerosing cholangitis (PSC) recurrence after liver transplant, according…
Children with progressive familial intrahepatic cholestasis (PFIC) who carry mutations that completely eliminate a protein’s production are nearly three times more likely to require…
FATTY LIVER DISEASE
NewsIn large trials, MASLD drug survodutide safely shrank liver fat, body weight
Survodutide, Boehringer Ingelheim’s investigational injectable therapy, significantly reduces liver fat and leads to clinically meaningful weight loss in obese or overweight people with metabolic…
Among people with chronic hepatitis D (CHD) infection, combination treatment regimens containing lonafarnib show benefits in easing disease burden and improving liver health. Specifically,…
A team of scientists has identified two key immune proteins — CD58 and IL7R — as therapeutic targets in primary biliary cholangitis (PBC), with…
A newly developed compound called HEP-50768 — identified through large-scale screening and chemically optimized to be more effective — was shown to significantly reduce itch…
FATTY LIVER DISEASE
NewsPatient advocates sought for Fatty Liver Foundation’s hands-on fellowship
The Fatty Liver Foundation (FLF) is seeking applicants for a first-of-its-kind program that trains patient advocates to become “equal partners” in shaping research, care,…
ALAGILLE SYNDROME
NewsNew lab-grown cells may improve Alagille syndrome variant testing
A new type of genetically engineered lab-grown cell may help researchers determine whether certain genetic variants can contribute to Alagille syndrome, a study reports.
Recent Posts
- Heart risks in Alagille syndrome may go beyond artery narrowing
- Maviret now approved in EU to treat acute hepatitis C virus infections
- Review identifies factors tied to PSC recurrence after liver transplant
- Adaptogens and MASH: To me, ‘probably fine’ is not a medical plan
- Kids with certain PFIC mutations more likely to need liver transplant